Sponsor or institution

Clinical trials and research at Newave Pharmaceutical Inc

As of November 12, 2026, Find a Trial lists 3 clinical trials run by Newave Pharmaceutical Inc that are recruiting, in United States. By phase: Phase 1 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Rocbrutinib versus pirtobrutinib for adults with relapsed or refractory CLL/SLL after a covalent BTK inhibitor Phase 3 Skokie, Illinois and 6 other locations Recruiting Jan 15, 2026
Oral treatment with LP-168 for patients with certain blood cancers Phase 1 Durham, North Carolina and 3 other locations Recruiting Mar 1, 2021
Oral treatment with LP-118 for patients with various blood cancers Phase 1 Chicago, Illinois and 7 other locations Recruiting Feb 25, 2021

All recruiting trials (3)

Quick answers

How many clinical trials run by Newave Pharmaceutical Inc are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.